Baxter's stock lagged broader market performance on August 4, 2025.
2 reports, 2 independent
Updated Aug 4
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Baxter's stock lagged broader market performance on August 4, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Baxter International
American manufacturer of healthcare goods
Nothing else this week.
Related events
- A financial comparison of market performance and risk profiles was conducted between Baxter International and Sysmex Corporation.
- Baxter International and Iridex Corporation are two healthcare companies that are currently facing market scrutiny.
- Baxter International and TELA Bio are two healthcare companies competing in the market.
Coverage
Newest first; wire copies grouped- BarchartAre Wall Street Analysts Bullish on Baxter International Stock? Valued at a market cap of $11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company headquartered in De
- StockStory3 Reasons to Avoid BAX and 1 Stock to Buy Instead Over the past six months, Baxter’s shares (currently trading at $27.77) have posted a disappointing 11.8% loss, well below the S&P 500’s 4.1% gain. T